Wildtype Kras2 can inhibit lung carcinogenesis in mice

Zhongqiu Zhang, Yian Wang, Haris G. Vikis, Leisa Johnson, Gongjie Liu, Jie Li, Marshall W. Anderson, Robert C. Sills, H. L. Hong, Theodora R. Devereux, Tyler Jacks, Kun Liang Guan, Ming You

Research output: Contribution to journalArticlepeer-review

266 Scopus citations


Although the ras genes have long been established as proto-oncogenes, the dominant role of activated ras in cell transformation has been questioned. Previous studies have shown frequent loss of the wildtype Kras2 allele in both mouse and human lung adenocarcinomas. To address the possible tumor suppressor role of wild-type Kras2 in lung tumorigenesis, we have carried out a lung tumor bioassay in heterozygous Kras2-deficient mice. Mice with a heterozygous Kras2 deficiency were highly susceptible to the chemical induction of lung tumors when compared to wildtype mice. Activating Kras2 mutations were detected in all chemically induced lung tumors obtained from both wildtype and heterozygous Kras2-deficient mice. Furthermore, wildtype Kras2 inhibited colony formation and tumor development by transformed NIH/3T3 cells and a mouse lung tumor cell line containing an activated Kras2 allele. Allelic loss of wildtype Kras2 was found in 67% to 100% of chemically induced mouse lung adenocarcinomas that harbor a mutant Kras2 allele. Finally, an inverse correlation between the level of wildtype Kras2 expression and extracellular signal-regulated kinase (ERK) activity was observed in these cells. These data strongly suggest that wildtype Kras2 has tumor suppressor activity and is frequently lost during lung tumor progression.

Original languageEnglish (US)
Pages (from-to)25-33
Number of pages9
JournalNature Genetics
Issue number1
StatePublished - 2001

ASJC Scopus subject areas

  • Genetics


Dive into the research topics of 'Wildtype Kras2 can inhibit lung carcinogenesis in mice'. Together they form a unique fingerprint.

Cite this